Inspira technologies oxy b.h.n. ltd.IINNW.US Overview

US StockHealthcare
(No presentation for IINNW)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

IINNW AI Insights

IINNW Overall Performance

IINNW AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

IINNW Recent Performance

22.86%

Inspira technologies oxy b.h.n. ltd.

-0.01%

Avg of Sector

0.34%

S&P500

IINNW PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check IINNW's Trend

IINNW Key Information

IINNW Valuation Metrics

IINNW Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Price of IINNW

IINNW FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

IINNW Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.53
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
0.69%
Net Margin
-2213.84%
Revenue Growth (YoY)
109.27%
Profit Growth (YoY)
100.06%
3-Year Revenue Growth
25.99%
3-Year Profit Growth
25.99%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.53
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
0.69%
Net Margin
-2213.84%
Revenue Growth (YoY)
109.27%
Profit Growth (YoY)
100.06%
3-Year Revenue Growth
25.99%
3-Year Profit Growth
25.99%

  • When is IINNW's latest earnings report released?

    The most recent financial report for Inspira technologies oxy b.h.n. ltd. (IINNW) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating IINNW's short-term business performance and financial health. For the latest updates on IINNW's earnings releases, visit this page regularly.

  • What is the operating profit of IINNW?

    According to the latest financial report, Inspira technologies oxy b.h.n. ltd. (IINNW) reported an Operating Profit of 3.62M with an Operating Margin of 2,503.46% this period, representing a growth of 24.61% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is IINNW's revenue growth?

    In the latest financial report, Inspira technologies oxy b.h.n. ltd. (IINNW) announced revenue of 144.5K, with a Year-Over-Year growth rate of 0%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does IINNW have?

    At the end of the period, Inspira technologies oxy b.h.n. ltd. (IINNW) held Total Cash and Cash Equivalents of 3.16M, accounting for 0.59 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is IINNW's EPS continuing to grow?

    According to the past four quarterly reports, Inspira technologies oxy b.h.n. ltd. (IINNW)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.12. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.